Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 2/20 | 0.52 |
| ▸ | MAOB | P27338 | 10/20 | 0.43 |
| ▸ | MAOA | P21397 | 2/20 | 0.43 |
| ▸ | PRKDC | P78527 | 2/20 | 0.42 |
| ▸ | GGPS1 | O95749 | 1/20 | 0.40 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.40 |
| ▸ | TNKS | O95271 | 1/20 | 0.39 |
| ▸ | PARP1 | P09874 | 1/20 | 0.39 |
| ▸ | TNKS2 | Q9H2K2 | 1/20 | 0.39 |
| ▸ | PARP2 | Q9UGN5 | 1/20 | 0.39 |
| ▸ | PTGES2 | Q9H7Z7 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4549416 | 0.92 | ALOX5 (0.53) | ALOX5MAOBMAOAPRKDCGGPS1 | |
| SCHEMBL4549415 | 0.91 | ALOX5 (0.51) | ALOX5MAOBMAOAPRKDCGGPS1 | |
| SCHEMBL4549414 | 0.90 | ALOX5 (0.52) | ALOX5MAOBMAOAPRKDCGGPS1 | |
| SCHEMBL9917231 | 0.88 | ALOX5 (0.57) | ALOX5MAOBMAOAPRKDCGGPS1 | |
| SCHEMBL4549366 | 0.86 | ALOX5 (0.60) | ALOX5MAOBPRKDCGGPS1PTGES2 | |
| SCHEMBL9917129 | 0.85 | ALOX5 (0.59) | ALOX5MAOBMAOAPRKDCGGPS1 | |
| SCHEMBL4549374 | 0.85 | ALOX5 (0.58) | ALOX5MAOBPRKDCGGPS1PTGES2 | |
| SCHEMBL4549438 | 0.85 | ALOX5 (0.50) | ALOX5MAOBMAOAPRKDCGGPS1 | |
| SCHEMBL6015220 | 0.84 | ALOX5 (0.60) | ALOX5MAOBPRKDCGGPS1ADORA3 | |
| SCHEMBL12380259 | 0.84 | ALOX5 (0.55) | ALOX5MAOBPRKDCGGPS1ADORA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9406889-B2 | Phenanthrene compound, light-emitting element, light-emitting device, electronic device, and lighting device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2016-08-02 | — | — | US | disclosed |
| US-9406889-B2 | Phenanthrene compound, light-emitting element, light-emitting device, electronic device, and lighting device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2016-08-02 | — | — | US | disclosed |
| US-20150171333-A1 | Phenanthrene Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2015-06-18 | — | — | US | disclosed |
| US-20150171333-A1 | Phenanthrene Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2015-06-18 | — | — | US | disclosed |
| US-8968888-B2 | Phenanthrene compound, light-emitting element, light-emitting device, electronic device, and lighting device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2015-03-03 | — | — | US | disclosed |
| US-8968888-B2 | Phenanthrene compound, light-emitting element, light-emitting device, electronic device, and lighting device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2015-03-03 | — | — | US | disclosed |
| US-20120104369-A1 | Phenanthrene Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2012-05-03 | — | — | US | disclosed |
| US-20120104369-A1 | Phenanthrene Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2012-05-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120104369-A1 | Phenanthrene Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device | MC1R, NR2E3, RPS19 | ALOX5 3393/4885MAOB 966/4885MAOA 961/4885 |
| US-20150171333-A1 | Phenanthrene Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device | MC1R, NR2E3, RPS19 | ALOX5 3393/4885MAOB 966/4885MAOA 961/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.